OTC Pharmaceuticals in South Africa
Published: August 2013 · Publisher: MarketLine
OTC Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
OTC Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The South African OTC pharmaceuticals market generated total revenues of $761.2m in 2012, representing a compound annual growth rate (CAGR) of 5.1% for the period spanning 2008-2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $281.8m, equivalent to 37% of the market's overall value.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.8% for the five-year period 2012-2017, which is expected to lead the market to a value of $917.1 by the end of 2016.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in South Africa
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in South Africa
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the South Africa otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the South Africa economy
Key Questions Answered
What was the size of the South Africa otc pharmaceuticals market by value in 2012?
What will be the size of the South Africa otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the South Africa otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in South Africa's otc pharmaceuticals market?
OTC Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The South African OTC pharmaceuticals market generated total revenues of $761.2m in 2012, representing a compound annual growth rate (CAGR) of 5.1% for the period spanning 2008-2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $281.8m, equivalent to 37% of the market's overall value.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.8% for the five-year period 2012-2017, which is expected to lead the market to a value of $917.1 by the end of 2016.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in South Africa
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in South Africa
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the South Africa otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the South Africa economy
Key Questions Answered
What was the size of the South Africa otc pharmaceuticals market by value in 2012?
What will be the size of the South Africa otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the South Africa otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in South Africa's otc pharmaceuticals market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Adcock Ingram Ltd, Pharma Natura (Pty) Ltd, Reckitt Benckiser Group plc and Weleda Group
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Market share 10
Market distribution 11
Market Outlook 12
Market value forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Adcock Ingram Ltd 19
Pharma Natura (Pty) Ltd 22
Reckitt Benckiser Group plc 23
Weleda Group 27
Macroeconomic Indicators 28
Country Data 28
Appendix 30
Methodology 30
Industry associations 31
Related research 31
LIST OF TABLES
Table 1: South Africa OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: South Africa OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: South Africa OTC pharmaceuticals market share: % share, by value, 2012 10
Table 4: South Africa OTC pharmaceuticals market distribution: % share, by value, 2012 11
Table 5: South Africa OTC pharmaceuticals market value forecast: $ million, 2012–17 12
Table 6: Adcock Ingram Ltd: key facts 19
Table 7: Adcock Ingram Ltd: key financials ($) 20
Table 8: Adcock Ingram Ltd: key financials (ZAR) 20
Table 9: Adcock Ingram Ltd: key financial ratios 20
Table 10: Pharma Natura (Pty) Ltd: key facts 22
Table 11: Reckitt Benckiser Group plc: key facts 23
Table 12: Reckitt Benckiser Group plc: key financials ($) 24
Table 13: Reckitt Benckiser Group plc: key financials (£) 24
Table 14: Reckitt Benckiser Group plc: key financial ratios 25
Table 15: Weleda Group : key facts 27
Table 16: South Africa size of population (million), 2008–12 28
Table 17: South Africa gdp (constant 2000 prices, $ billion), 2008–12 28
Table 18: South Africa gdp (current prices, $ billion), 2008–12 28
Table 19: South Africa inflation, 2008–12 29
Table 20: South Africa consumer price index (absolute), 2008–12 29
Table 21: South Africa exchange rate, 2008–12 29
LIST OF FIGURES
Figure 1: South Africa OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: South Africa OTC pharmaceuticals market share: % share, by value, 2012 10
Figure 4: South Africa OTC pharmaceuticals market distribution: % share, by value, 2012 11
Figure 5: South Africa OTC pharmaceuticals market value forecast: $ million, 2012–17 12
Figure 6: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2012 13
Figure 7: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2012 14
Figure 8: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2012 15
Figure 9: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2012 16
Figure 10: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2012 17
Figure 11: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2012 18
Figure 12: Adcock Ingram Ltd: revenues & profitability 21
Figure 13: Adcock Ingram Ltd: assets & liabilities 21
Figure 14: Reckitt Benckiser Group plc: revenues & profitability 25
Figure 15: Reckitt Benckiser Group plc: assets & liabilities 26
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Market share 10
Market distribution 11
Market Outlook 12
Market value forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Adcock Ingram Ltd 19
Pharma Natura (Pty) Ltd 22
Reckitt Benckiser Group plc 23
Weleda Group 27
Macroeconomic Indicators 28
Country Data 28
Appendix 30
Methodology 30
Industry associations 31
Related research 31
LIST OF TABLES
Table 1: South Africa OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: South Africa OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: South Africa OTC pharmaceuticals market share: % share, by value, 2012 10
Table 4: South Africa OTC pharmaceuticals market distribution: % share, by value, 2012 11
Table 5: South Africa OTC pharmaceuticals market value forecast: $ million, 2012–17 12
Table 6: Adcock Ingram Ltd: key facts 19
Table 7: Adcock Ingram Ltd: key financials ($) 20
Table 8: Adcock Ingram Ltd: key financials (ZAR) 20
Table 9: Adcock Ingram Ltd: key financial ratios 20
Table 10: Pharma Natura (Pty) Ltd: key facts 22
Table 11: Reckitt Benckiser Group plc: key facts 23
Table 12: Reckitt Benckiser Group plc: key financials ($) 24
Table 13: Reckitt Benckiser Group plc: key financials (£) 24
Table 14: Reckitt Benckiser Group plc: key financial ratios 25
Table 15: Weleda Group : key facts 27
Table 16: South Africa size of population (million), 2008–12 28
Table 17: South Africa gdp (constant 2000 prices, $ billion), 2008–12 28
Table 18: South Africa gdp (current prices, $ billion), 2008–12 28
Table 19: South Africa inflation, 2008–12 29
Table 20: South Africa consumer price index (absolute), 2008–12 29
Table 21: South Africa exchange rate, 2008–12 29
LIST OF FIGURES
Figure 1: South Africa OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: South Africa OTC pharmaceuticals market share: % share, by value, 2012 10
Figure 4: South Africa OTC pharmaceuticals market distribution: % share, by value, 2012 11
Figure 5: South Africa OTC pharmaceuticals market value forecast: $ million, 2012–17 12
Figure 6: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2012 13
Figure 7: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2012 14
Figure 8: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2012 15
Figure 9: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2012 16
Figure 10: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2012 17
Figure 11: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2012 18
Figure 12: Adcock Ingram Ltd: revenues & profitability 21
Figure 13: Adcock Ingram Ltd: assets & liabilities 21
Figure 14: Reckitt Benckiser Group plc: revenues & profitability 25
Figure 15: Reckitt Benckiser Group plc: assets & liabilities 26
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.